What is BioCryst Pharmaceuticals's investment purchases?

BioCryst Pharmaceuticals (BCRX) reported investment purchases of $0 in Q1 2026.

How has BioCryst Pharmaceuticals's investment purchases changed year-over-year?

BioCryst Pharmaceuticals's investment purchases decreased by 100.0% year-over-year, from $48.76M to $0.

What is the long-term trend for BioCryst Pharmaceuticals's investment purchases?

Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's investment purchases has grown at a 126.2% compound annual growth rate (CAGR), from $10.01M to $262.24M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

BioCryst Pharmaceuticals BCRX Investment Purchases

Investment Purchases at other companies

Ionis PharmaceuticalsIONS

$192.76M-38.0%

Ultragenyx PharmaceuticalRARE

$131M—

AnaptysBio, Inc.ANAB

$0-100%

BridgeBio PharmaBBIO

$52.67M—

Arrowhead ResearchARWR

$924.64M+43.5%

Agios PharmaceuticalsAGIO

$148.18M-15.3%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's investment purchases?: BioCryst Pharmaceuticals (BCRX) reported investment purchases of $0 in Q1 2026.
How has BioCryst Pharmaceuticals's investment purchases changed year-over-year?: BioCryst Pharmaceuticals's investment purchases decreased by 100.0% year-over-year, from $48.76M to $0.
What is the long-term trend for BioCryst Pharmaceuticals's investment purchases?: Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's investment purchases has grown at a 126.2% compound annual growth rate (CAGR), from $10.01M to $262.24M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.